Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
States challenge Trump's executive order halting wind energy projects, arguing it exceeds his authority and undermines climate goals.
US services sector shows resilience amid inflation concerns, with growth picking up in April despite supply chain challenges and tariff uncertainty.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
States challenge Trump's executive order halting wind energy projects, arguing it exceeds his authority and undermines climate goals.
US services sector shows resilience amid inflation concerns, with growth picking up in April despite supply chain challenges and tariff uncertainty.